Skip to end of metadata
Go to start of metadata
Date

 

Chair
StatusPlanned
Comments

Dial-in Number

  • One tap mobile
    +13126266799,,3231998494# US (Chicago)
    +13462487799,,3231998494# US (Houston)
  • Dial by your location
    +1 312 626 6799 US (Chicago)
    +1 346 248 7799 US (Houston)
    +1 669 900 6833 US (San Jose)
    +1 929 436 2866 US (New York)
    +1 253 215 8782 US
    +1 301 715 8592 US
    Meeting ID: 323 199 8494
    Find your local number: https://zoom.us/u/aLIcTlITh

Web session

HL7 Antitrust Policy

Professional Associations, such as HL7, which bring together competing entities are subject to strict scrutiny under applicable antitrust laws. HL7 recognizes that the antitrust laws were enacted to promote fairness in competition and, as such, supports laws against monopoly and restraints of trade and their enforcement. Each individual participating in HL7 meetings and conferences, regardless of venue, is responsible for knowing the contents of and adhering to the HL7 Antitrust Policy as stated in §05.01 of the Governance and Operations Manual (GOM).

Attendees

Please include your organization in your Zoom name.

  • Click on your picture/name in Zoom
  • Click on rename
  • enter <name> - <organization>
NameOrganizationPresent
Danielle BancroftBest Practice Software
Melva Peters (Chair)Jenaker Consultingx
Jean Duteau Duteau Design
John HatemIndependent Consultantx
Scott Robertson Kaiser Permanente
Christof GessnerHL7 Germany
Corey SpearsMITRE
Dave HillMITRE
Frank McKinneyPOCPx
Isaac VetterEpic
Joe QuinnSmile CDRx
Lawrence LoColumbia University HIT Student
Margaret WeikerNCPDP
Matt SzczepankiewiczEpic
Peter SergentHL7 New Zealandx
Reed D. GelzerTrustworthy EHR
Shelly SpiroPharmacy HIT Collaborativex
Stephen ChuADHAx
Tim McNeilSurescripts
Kim RobertsPharmacy HIT Collaborative
Kent BulzaWell Health
Phung Matthews3Mx
Jack BrashierEpic
Emmanuel Obasuyi

Joel MontavonPQA
Robb YoungPharmID
Christopher Isong

Gary SchoettmerNetRxx
Courtney BlandCVS / Aetna
Mark NeumuthAetna
Ed MillikanFDA
Sanket RavalCVS / Aetna

Agenda Items and Notes

Outstanding Action Item List

Meeting Notes from previous meeting

2022-06-20 Agenda/Meeting Notes - corrected Tom's last name and company - accepted by General Consent

Project Review

Project Proposals

  • Project Proposals in Review - none to review.  While two proposals came up, Melva has reviewed them both on the June 13 conference call. 

Project Scope Statements

External Meeting Review

Catalog Updates (John Hatem)

  • - reviewed existing ballot materials - next meeting is July 8th
    • Catalog project open to meeting - ask us to go to their meeting on Fridays at 12 noon Eastern
      • Best date at this point is Sept 2, or Sept 9, 2022, since Francois is out all of August and I am out all of July. 
    • FYI, the IG work will not be balloted in Sept, 2022 WGM - many open issues. 

Workflow Update (John Hatem) 

  • - Meeting cancelled this week

Healthcare Product Update (John Hatem)

  • - Addressing trackers for BDP and other resources. This work also included improving descriptions for several elements and reviewing the value sets. No Pharmacy impact at this time. 

EHR conformant reconciled medication list (cRML) (Scott Robertson / John Hatem)

  • - have not been meeting
    • may be meeting with NCPDP on July 6th
    • Shelly has a Masters Student (until April 2023 for project) who will be doing thesis on Standardized Medication List - funding and how to move foward
      • cRML is part of this - hope to get it moving again

NCPDP Updates (NCPDP Members)

WG18 Patient Consent TG:

  •  
    • Addition of Consent to HL7 Specialty Rx FHIR IG  will be balloted as a new version of the Specialty Medication Enrollment Guide in September
    • Connectathon
      • New application was created that illustrates the content of the implementation guide and it demonstrates how the application will use the standard that is defined to request the consent and provide the appropriate consent form to the clinic.
      • The clinic can see the request and work it in to the workflow process, update the request, complete the request, and view it.
      • Focus is on the exchange process while the patient is at the clinic
      • In this process there is still exchange of PDFs
    • Link for Consent Simulator - Patient Requester View
      • From this page it is possible to view the form, submit request and view the status of consent
    • There will be a discussion with the HL7 Community Based Care and Privacy WG in the next couple of weeks to review the plan and what was learned at the Connectathon
      • They will be co-sponsoring the effort to add consent to the guide and take this to ballot
    • NCPDP Meetings are scheduled for June 23, July 7, and July 21st at 11:00 am US Central Time
    • NIB - Melva to create draft and send to Frank to complete
  • - NIB needed
    • Frank working on content - must have content for review for next weeks meeting
    • there are some things in the IG that could be corrected - examples could be corrected
      • create Jira issues as technical corrections that can be included
      • NIB doesn't have to call them out, but they should be included in the IG version history

MC Consumer and Provider RTPB Standards Monitoring Sub-Task Group

  •  
    • HL7® FHIR® Jira tickets status for RTPB Standard vs Consumer RTPB Check Imp Guide gaps have been submitted. Waiting on CARIN Alliance. The sub-TG continues to monitor state legislation and regulations.
    • NCPDP Meetings are scheduled for June 27, July 11 and July 25 at 12:00 pm US Central Time
  • no update
  • - didn't meeting this week
    • will meet as needed
    • CARIN IG - haven't moved forward with updates to the IG
      • Frank informally responding to questions
    • NCPDP group is monitoring legislative changes and impact on NCPDP standard and CARIN IG

All NCPDP Meeting information can be obtained at https://dms.ncpdp.org/

Projects

PDex Formulary (Corey)

  • - no update
  • - no update

Pharmacist Consult Note (Scott)

  •  
    • NCPDP TG decided to continue with the HL7/NCPDP guidance document and possibly tackle an IG at a later date.
    • NCPDP meetings are scheduled for June 16, June 30, and July 14 at 10:00 am US Central Time
  •  
    • NIB for approval - reviewed and updated
    • Motion - Scott and Margaret to approve NIB - 11-0-0 Carried
  •  
    • NIB submitted
    • working on content - working on additional use cases
  • - no update

FHIR (Group)

Trackers - link to pharmacy unresolved Jira trackers (see trackers for details / resolutions)

  • none to discuss

Any Other Business

  • John will be off for the month of July

Next meeting:

  •